Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63
Teratogenicity01:07

Teratogenicity

2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

184
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
184
Hazard Rate01:11

Hazard Rate

89
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
89
Relative Risk01:12

Relative Risk

117
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
117
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

97
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
97

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Previable Preterm Premature Rupture of the Membranes Reaching Viability: Canadian Outcomes.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2026
Same author

A cluster randomized controlled trial (GOAL trial) evaluated a comprehensive geriatric assessment for frail older people with chronic kidney disease.

Kidney international·2026
Same author

Coping as a mediator between family stressors and behavioural adjustment in siblings of children with progressive life-limiting conditions: a multilevel longitudinal study.

BMC pediatrics·2026
Same author

Selective early medical treatment of the patent ductus arteriosus in extremely low gestational age infants: a pilot randomised controlled trial (SMART-PDA).

Archives of disease in childhood. Fetal and neonatal edition·2026
Same author

What Matters Most: The Top 10 Child and Adolescent Cancer Research Priorities in Australia.

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

An Empirical Comparison of Statistical Methods for Estimating Treatment Effects on EQ-5D in Randomized Clinical Trials.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Personalizing N-of-1 Trial Results to Facilitate Decision-Making.

JAMA network open·2026
Same journal

Prostate Cancer Screening-Where We've Been, Where We Are, and What Comes Next.

JAMA network open·2026
Same journal

Comparison of Care Cascade Outcome Measures for Hepatitis C Among Insured US Adults.

JAMA network open·2026
Same journal

At-Home Transvaginal Pelvic Ultrasonography and Image Quality in Premenopausal Women: A Nonrandomized Clinical Trial.

JAMA network open·2026
Same journal

Aerobic Exercise and Subthreshold Depressive Symptoms in Adolescents: Secondary Analysis of a Randomized Clinical Trial.

JAMA network open·2026
Same journal

Prefrontal Transcranial Pulse Stimulation for Major Depressive Disorder: A Randomized Clinical Trial.

JAMA network open·2026
See all related articles

Related Experiment Video

Updated: Jun 7, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

11.3K

Short-Term and Long-Term Mortality Risk After Preterm Birth.

Asma M Ahmed1, Sonia M Grandi2, Eleanor Pullenayegum2

  • 1Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

JAMA Network Open
|November 20, 2024
PubMed
Summary
This summary is machine-generated.

Preterm birth (PTB) increases mortality risk throughout childhood and into adulthood. This risk is highest in infancy and decreases with age, highlighting PTB as a significant long-term health concern.

More Related Videos

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

10.3K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

85.8K

Related Experiment Videos

Last Updated: Jun 7, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

11.3K
A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

10.3K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

85.8K

Area of Science:

  • Public Health
  • Epidemiology
  • Perinatal Medicine

Background:

  • Preterm birth (PTB) is a primary cause of neonatal mortality.
  • Limited data exist on mortality risks beyond the neonatal period for PTB survivors, particularly in North America.

Purpose of the Study:

  • To investigate the association between PTB and all-cause and cause-specific mortality from birth through 36 years of age.

Main Methods:

  • A population-based matched cohort study in Canada included live births from 1983-1996, followed until 2019.
  • Gestational age-specific PTB (24-37 weeks) was compared to term births (37-41 weeks).
  • Statistical analyses included log-binomial and Cox proportional hazards regression, with coarsened exact matching for confounding.

Main Results:

  • PTB was linked to increased mortality risk across all age intervals studied (0-36 years).
  • The highest risks were observed in infancy (0-11 months) and early childhood (1-5 years).
  • Increased mortality risks were associated with respiratory, circulatory, digestive, nervous system, endocrine, infectious diseases, cancers, and perinatal conditions.

Conclusions:

  • Individuals born preterm face elevated mortality risks extending into their fourth decade of life.
  • The risk of mortality is inversely related to gestational age.
  • PTB should be considered a significant risk factor for long-term mortality, informing the development of preventive strategies.